Search Results - "Epis, O. M."

Neurological manifestations in patients hospitalized with COVID‐19: A retrospective analysis from a large cohort in Northern Italy.

Authors: Travi, Giovanna Rossotti, Roberto Merli, Marco et al.

Source: European Journal of Neuroscience. Apr2021, Vol. 53 Issue 8, p2912-2922. 11p. 4 Charts, 1 Graph.

Subjects: COVID-19, Neurologic manifestations of general diseases, Symptoms, Stroke, Neurological disorders, Central nervous system

Geographic Terms: Northern Italy

Age-Specific Patterns in Biologic and Targeted Synthetic DMARDs Discontinuation and Drug-Specific Risks.

Authors: Gheshmi, Nasreh Shamsi Poor Khan, Amer Hayat Syed Sulaiman, Syed Azhar et al.

Source: Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia. Jan-Mar2025, Vol. 36 Issue 1, p145-156. 12p.

A novel inhibitor of class IIa histone deacetylases attenuates collagen‐induced arthritis.

Authors: Poon, Eunice K. Liu, Ligong Wu, Kai‐Chen et al.

Source: British Journal of Pharmacology. Dec2024, Vol. 181 Issue 23, p4804-4821. 18p.

COVID-19: An Overview of SARS-CoV-2 Variants—The Current Vaccines and Drug Development.

Authors: Bostanghadiri, Narjess Ziaeefar, Pardis Mofrad, Morvarid Golrokh et al.

Source: BioMed Research International. 8/29/2023, p1-29. 29p.

Impact of new‐onset and preexisting neurological disorders in COVID‐19 patients.

Authors: Lindemann, Sarah Böhm, Markus Gonnert, Falk et al.

Source: Brain & Behavior. Jul2023, Vol. 13 Issue 7, p1-11. 11p.

Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis.

Authors: Fang, Qinghua Ou, Jiaxin Nandakumar, Kutty Selva

Source: Mediators of Inflammation. 10/27/2019, p1-22. 22p.

Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients?

Authors: Kotyla, Przemyslaw J.¹

Source: BioMed Research International. 5/10/2018, Vol. 2018, p1-9. 9p.

Antibodies against mutated citrullinated vimentin fail to predict anti-TNFα treatment response in rheumatoid arthritis.

Authors: Dejaco, C. Duftner, C. Klotz, W. et al.

Source: Scandinavian Journal of Rheumatology. Jan2009, Vol. 38 Issue 1, p66-67. 2p. 1 Chart.

Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review.

Authors: Sozzani, Silvano Abbracchio, Maria P. Annese, Vito et al.

Source: Autoimmunity. Aug2014, Vol. 47 Issue 5, p287-306. 20p.

Atrial Fibrillation and Clinical Outcomes in a Cohort of Hospitalized Patients with Sars-Cov-2 Infection and Chronic Kidney Disease.

Authors: Genovesi, Simonetta Rebora, Paola Occhino, Giuseppe et al.

Source: Journal of Clinical Medicine. Sep2021, Vol. 10 Issue 18, p4108. 1p.

Undifferentiated Connective Tissue Disease in Pregnancy: A Topic Yet to be Explored.

Authors: Serena C Clemenza S Simeone S et al.

Source: Frontiers in pharmacology [Front Pharmacol] 2022 Jan 20; Vol. 13, pp. 820760. Date of Electronic Publication: 2022 Jan 20 (Print Publication: 2022).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

Chemical Engineering and Material Properties II

Authors: Bin Li

Resource Type: eBook.

Subjects: Chemical engineering--Congresses, Materials--Congresses

Categories: TECHNOLOGY & ENGINEERING / Materials Science / General